{"id":"https://openalex.org/W3210244313","doi":"https://doi.org/10.1248/bpb.b21-00512","title":"Pharmacological Inhibition of Transient Receptor Potential Vanilloid 4 Reduces Vasogenic Edema after Traumatic Brain Injury in Mice","display_name":"Pharmacological Inhibition of Transient Receptor Potential Vanilloid 4 Reduces Vasogenic Edema after Traumatic Brain Injury in Mice","publication_year":2021,"publication_date":"2021-10-31","ids":{"openalex":"https://openalex.org/W3210244313","doi":"https://doi.org/10.1248/bpb.b21-00512","mag":"3210244313","pmid":"https://pubmed.ncbi.nlm.nih.gov/34719652"},"language":"en","primary_location":{"id":"doi:10.1248/bpb.b21-00512","doi":"https://doi.org/10.1248/bpb.b21-00512","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.b21-00512","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/44/11/44_b21-00512/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.jstage.jst.go.jp/article/bpb/44/11/44_b21-00512/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039434669","display_name":"Shotaro Michinaga","orcid":"https://orcid.org/0000-0002-4052-7507","observed_orcids":["https://orcid.org/0000-0002-4052-7507"]},"institutions":[{"id":"https://openalex.org/I23172683","display_name":"Meiji Pharmaceutical University","ror":"https://ror.org/00wm7p047","country_code":"JP","type":"education","lineage":["https://openalex.org/I23172683"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shotaro Michinaga","raw_affiliation_strings":["Department of Pharmacodynamics, Meiji Pharmaceutical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacodynamics, Meiji Pharmaceutical University","institution_ids":["https://openalex.org/I23172683"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058500799","display_name":"Kazuya Onishi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I167598709","display_name":"Osaka Ohtani University","ror":"https://ror.org/01jtn9895","country_code":"JP","type":"education","lineage":["https://openalex.org/I167598709"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuya Onishi","raw_affiliation_strings":["Laboratory of Pharmacology, Faculty of Pharmacy, Osaka Ohtani University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmacology, Faculty of Pharmacy, Osaka Ohtani University","institution_ids":["https://openalex.org/I167598709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006183918","display_name":"Kahori Shimizu","orcid":"https://orcid.org/0000-0003-1574-5526","observed_orcids":["https://orcid.org/0000-0003-1574-5526"]},"institutions":[{"id":"https://openalex.org/I167598709","display_name":"Osaka Ohtani University","ror":"https://ror.org/01jtn9895","country_code":"JP","type":"education","lineage":["https://openalex.org/I167598709"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kahori Shimizu","raw_affiliation_strings":["Laboratory of Biochemistry, Faculty of Pharmacy, Osaka Ohtani University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Biochemistry, Faculty of Pharmacy, Osaka Ohtani University","institution_ids":["https://openalex.org/I167598709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102921416","display_name":"Hiroyuki Mizuguchi","orcid":"https://orcid.org/0000-0002-2497-8033","observed_orcids":["https://orcid.org/0000-0002-2497-8033"]},"institutions":[{"id":"https://openalex.org/I167598709","display_name":"Osaka Ohtani University","ror":"https://ror.org/01jtn9895","country_code":"JP","type":"education","lineage":["https://openalex.org/I167598709"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroyuki Mizuguchi","raw_affiliation_strings":["Laboratory of Pharmacology, Faculty of Pharmacy, Osaka Ohtani University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmacology, Faculty of Pharmacy, Osaka Ohtani University","institution_ids":["https://openalex.org/I167598709"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085640969","display_name":"Shigeru Hishinuma","orcid":"https://orcid.org/0000-0001-8479-6541","observed_orcids":["https://orcid.org/0000-0001-8479-6541"]},"institutions":[{"id":"https://openalex.org/I23172683","display_name":"Meiji Pharmaceutical University","ror":"https://ror.org/00wm7p047","country_code":"JP","type":"education","lineage":["https://openalex.org/I23172683"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shigeru Hishinuma","raw_affiliation_strings":["Department of Pharmacodynamics, Meiji Pharmaceutical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacodynamics, Meiji Pharmaceutical University","institution_ids":["https://openalex.org/I23172683"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.9313,"has_fulltext":true,"cited_by_count":17,"citation_normalized_percentile":{"value":0.69093231,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"44","issue":"11","first_page":"1759","last_page":"1766"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.5185999870300293,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.5185999870300293,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10706","display_name":"Traumatic Brain Injury and Neurovascular Disturbances","score":0.4514000117778778,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11204","display_name":"Ion Channels and Receptors","score":0.006899999920278788,"subfield":{"id":"https://openalex.org/subfields/2809","display_name":"Sensory Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trpv4","display_name":"TRPV4","score":0.921999990940094},{"id":"https://openalex.org/keywords/transient-receptor-potential-vanilloid-4","display_name":"transient receptor potential vanilloid 4","score":0.9340000152587891},{"id":"https://openalex.org/keywords/vasogenic-edema","display_name":"vasogenic edema","score":0.8960000276565552},{"id":"https://openalex.org/keywords/traumatic-brain-injury","display_name":"traumatic brain injury","score":1.0},{"id":"https://openalex.org/keywords/blood-brain-barrier-disruption","display_name":"blood-brain barrier disruption","score":0.9879999756813049},{"id":"https://openalex.org/keywords/trpv4-antagonist","display_name":"TRPV4 antagonist","score":0.9300000071525574},{"id":"https://openalex.org/keywords/hc-067047","display_name":"HC-067047","score":0.9810000061988831},{"id":"https://openalex.org/keywords/fluid-percussion-injury","display_name":"fluid percussion injury","score":0.9589999914169312},{"id":"https://openalex.org/keywords/astrocytes","display_name":"astrocytes","score":0.8309999704360962},{"id":"https://openalex.org/keywords/mmp-9","display_name":"MMP-9","score":0.9649999737739563},{"id":"https://openalex.org/keywords/vegf-a","display_name":"VEGF-A","score":0.9169999957084656},{"id":"https://openalex.org/keywords/endothelin-1","display_name":"endothelin-1","score":0.9879999756813049},{"id":"https://openalex.org/keywords/brain-water-content","display_name":"brain water content","score":0.6980000138282776},{"id":"https://openalex.org/keywords/evans-blue-extravasation","display_name":"Evans blue extravasation","score":0.9639999866485596}],"concepts":[{"id":"https://openalex.org/C2779540182","wikidata":"https://www.wikidata.org/wiki/Q1076345","display_name":"Extravasation","level":2,"score":0.9280226230621338},{"id":"https://openalex.org/C2777649898","wikidata":"https://www.wikidata.org/wiki/Q5415983","display_name":"Evans Blue","level":2,"score":0.8137675523757935},{"id":"https://openalex.org/C90420996","wikidata":"https://www.wikidata.org/wiki/Q15324120","display_name":"TRPV4","level":4,"score":0.7293584942817688},{"id":"https://openalex.org/C2781017439","wikidata":"https://www.wikidata.org/wiki/Q1995526","display_name":"Traumatic brain injury","level":2,"score":0.717390775680542},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6040221452713013},{"id":"https://openalex.org/C2778402981","wikidata":"https://www.wikidata.org/wiki/Q221694","display_name":"Blood\u2013brain barrier","level":3,"score":0.5932204127311707},{"id":"https://openalex.org/C2780886150","wikidata":"https://www.wikidata.org/wiki/Q152234","display_name":"Edema","level":2,"score":0.5772719383239746},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5284825563430786},{"id":"https://openalex.org/C155164980","wikidata":"https://www.wikidata.org/wiki/Q304043","display_name":"Transient receptor potential channel","level":3,"score":0.4708858132362366},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.41171061992645264},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.33192330598831177},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3149194121360779},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2891874313354492},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.24013397097587585},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.19658750295639038},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000070642","descriptor_name":"Brain Injuries, Traumatic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000070642","descriptor_name":"Brain Injuries, Traumatic","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001253","descriptor_name":"Astrocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001812","descriptor_name":"Blood-Brain Barrier","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001929","descriptor_name":"Brain Edema","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001929","descriptor_name":"Brain Edema","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020780","descriptor_name":"Matrix Metalloproteinase 9","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D050916","descriptor_name":"TRPV Cation Channels","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D050916","descriptor_name":"TRPV Cation Channels","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060888","descriptor_name":"Real-Time Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1248/bpb.b21-00512","doi":"https://doi.org/10.1248/bpb.b21-00512","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.b21-00512","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/44/11/44_b21-00512/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},{"id":"pmid:34719652","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34719652","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological & pharmaceutical bulletin","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1248/bpb.b21-00512","doi":"https://doi.org/10.1248/bpb.b21-00512","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.b21-00512","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/44/11/44_b21-00512/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5212397953","display_name":"Development of novel therapeutic drugs for traumatic brain injury focused on functional molecules in astrocytes","funder_award_id":"20K16016","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3210244313.pdf","grobid_xml":"https://content.openalex.org/works/W3210244313.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W583881585","https://openalex.org/W1493831502","https://openalex.org/W1519585367","https://openalex.org/W1995785702","https://openalex.org/W2003890250","https://openalex.org/W2008479646","https://openalex.org/W2013399980","https://openalex.org/W2019778468","https://openalex.org/W2029048308","https://openalex.org/W2057974205","https://openalex.org/W2065232910","https://openalex.org/W2073576822","https://openalex.org/W2086448856","https://openalex.org/W2094458351","https://openalex.org/W2098841206","https://openalex.org/W2100557964","https://openalex.org/W2105443363","https://openalex.org/W2111982133","https://openalex.org/W2128440535","https://openalex.org/W2169454631","https://openalex.org/W2170724437","https://openalex.org/W2323939613","https://openalex.org/W2560014610","https://openalex.org/W2608107406","https://openalex.org/W2623218438","https://openalex.org/W2627401075","https://openalex.org/W2784015117","https://openalex.org/W2802588136","https://openalex.org/W2804202862","https://openalex.org/W2884424144","https://openalex.org/W2898523507","https://openalex.org/W2946016906","https://openalex.org/W2960774789","https://openalex.org/W2999662108","https://openalex.org/W3012721989","https://openalex.org/W3021573204","https://openalex.org/W3036279865","https://openalex.org/W3036506251"],"related_works":["https://openalex.org/W2560014610","https://openalex.org/W2094458351","https://openalex.org/W4320723713","https://openalex.org/W2897293211","https://openalex.org/W2012727285","https://openalex.org/W2795254042","https://openalex.org/W3011365474","https://openalex.org/W2057296065","https://openalex.org/W4210545171","https://openalex.org/W3081059545"],"abstract_inverted_index":{"Vasogenic":[0,93],"edema":[1,71,95],"results":[2,225],"from":[3],"blood-brain":[4],"barrier":[5],"(BBB)":[6],"disruption":[7,98],"after":[8],"traumatic":[9],"brain":[10,58,94,103,112,117,137,196],"injury":[11,84],"(TBI),":[12],"and":[13,43,90,96,106,120,133,140,156,181,203,214],"although":[14],"it":[15],"can":[16],"be":[17,51,191,235],"fatal,":[18],"no":[19],"promising":[20,237],"therapeutic":[21,238],"drugs":[22],"have":[23],"been":[24],"developed":[25],"as":[26],"yet.":[27],"Transient":[28],"receptor":[29],"potential":[30],"vanilloid":[31],"4":[32],"(TRPV4)":[33],"is":[34,39,48,232],"a":[35,236],"calcium-permeable":[36],"channel":[37],"that":[38,152,194,227],"sensitive":[40],"to":[41,50,190,220,234],"temperature":[42],"osmotic":[44],"pressure.":[45],"As":[46],"TRPV4":[47,66,130,186,231],"known":[49],"responsible":[52],"for":[53,169,240],"various":[54],"pathological":[55],"conditions":[56],"following":[57],"injury,":[59],"we":[60],"investigated":[61],"the":[62,87,128,159,206],"effects":[63],"of":[64,127,154,165,211,230],"pharmacological":[65,228],"antagonists":[67,131],"on":[68,102],"TBI-induced":[69,242],"vasogenic":[70,243],"in":[72,86,144,162,195,208,216,221],"this":[73],"study.":[74],"A":[75],"TBI":[76],"model":[77],"was":[78,188],"established":[79],"by":[80],"inflicting":[81],"fluid":[82],"percussion":[83],"(FPI)":[85],"mouse":[88],"cerebrum":[89],"cultured":[91,217],"astrocytes.":[92],"BBB":[97,170],"were":[99],"assessed":[100],"based":[101],"water":[104,118,138],"content":[105,119,139],"Evans":[107],"blue":[108],"(EB)":[109],"extravasation":[110,122,143],"into":[111],"tissue,":[113],"respectively.":[114],"After":[115],"FPI,":[116],"EB":[121,142],"increased.":[123],"Repeated":[124],"intracerebroventricular":[125],"administration":[126,153],"specific":[129],"HC-067047":[132,155,202],"RN-1734":[134,157,204],"dose-dependently":[135],"reduced":[136],"alleviated":[141],"FPI":[145],"mice.":[146],"Additionally,":[147],"real-time":[148],"PCR":[149],"analysis":[150],"indicated":[151],"reversed":[158],"FPI-induced":[160],"increase":[161,207],"mRNA":[163,209],"levels":[164,210],"endogenous":[166],"causal":[167],"factors":[168],"disruption,":[171],"including":[172],"matrix":[173],"metalloproteinase-9":[174],"(MMP-9),":[175],"vascular":[176],"endothelial":[177,198],"growth":[178],"factor-A":[179],"(VEGF-A),":[180],"endothelin-1":[182],"(ET-1).":[183],"In":[184],"astrocytes,":[185],"level":[187],"observed":[189],"higher":[192],"than":[193],"microvascular":[197],"cells.":[199],"Treatment":[200],"with":[201],"inhibited":[205],"MMP-9,":[212],"VEGF-A,":[213],"ET-1":[215],"astrocytes":[218],"subjected":[219],"vitro":[222],"FPI.":[223],"These":[224],"suggest":[226],"inhibition":[229],"expected":[233],"strategy":[239],"treating":[241],"edema.":[244]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2021-11-08T00:00:00"}